Unknown

Dataset Information

0

Early Vitamin C, Hydrocortisone, and Thiamine Treatment for Septic Cardiomyopathy: A Propensity Score Analysis.


ABSTRACT: This study investigated the effectiveness of early vitamin C, hydrocortisone, and thiamine among patients with septic cardiomyopathy. In total, 91 patients with septic cardiomyopathy received a vitamin C protocol in September 2018-February 2020. These patients were compared to 75 patients with septic cardiomyopathy who did not receive a vitamin C protocol in September 2016-February 2018. Relative to the control patients, the treated patients were older and more likely to require mechanical ventilation. The vitamin C protocol was associated with a lower risk of intensive care unit mortality in the propensity score (PS)-matched cohort (aHR: 0.55, 95% CI: 0.30-0.99) and inverse probability of treatment weighting-matched cohort (aHR: 0.67, 95% CI: 0.45-1.00). In the PS-matched cohort (59 patients per group), the vitamin C protocol was associated with decreased values for vasopressor dosage, C-reactive protein concentration, and the Sequential Organ Failure Assessment score during the 4-day treatment period. Patients who started the vitamin C protocol within 2 h after diagnosis (vs. 2-8 h or ≥8 h) had the highest vasopressor weaning rate and the lowest mortality rate. These results suggest that early treatment using a vitamin C protocol might improve organ dysfunction and reduce mortality among patients with septic cardiomyopathy.

SUBMITTER: Lee MT 

PROVIDER: S-EPMC8304272 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6950320 | biostudies-literature
| S-EPMC6352246 | biostudies-other
| S-EPMC8660008 | biostudies-literature
| S-EPMC8684090 | biostudies-literature
| S-EPMC7029761 | biostudies-literature
| S-EPMC7024754 | biostudies-literature
| S-EPMC7023737 | biostudies-literature
| S-EPMC8254386 | biostudies-literature
| S-EPMC7005175 | biostudies-literature
| S-EPMC11340010 | biostudies-literature